Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · August 23, 2023

Efficacy and Safety of 1% and 2% Rebamipide Clear Solution in Patients With Dry Eye Disease

BMC Ophthalmology


Additional Info

Disclosure statements are available on the authors' profiles:

BMC Ophthalmology
Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial
BMC Ophthalmol 2023 Aug 03;23(1)343, Y Eom, SH Chung, TY Chung, JY Kim, CY Choi, KC Yoon, BY Ko, HK Kim, MK Kim, HK Lee, JS Song, JY Hyon, KY Seo, JS Lee, HM Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading